Skip to main content
. Author manuscript; available in PMC: 2009 Jun 9.
Published in final edited form as: Clin Genet. 2008 May 21;74(2):97–104. doi: 10.1111/j.1399-0004.2008.01027.x

Fig. 4.

Fig. 4

Serum phenylalanine levels of Pahenu2 mice following recombinant adeno-associated virus (rAAV)8 vector administration. Five Pahenu2/Pahenu2 mice received 5 × 1011 vector genomes of phenylalanine hydroxylase (PAH)-expressing rAAV8 through portal vein injection, and serum phenylalanine levels were measured weekly thereafter. A single Pahenu2/Pahenu2 mouse received a saline injection as a control. The data are expressed as mean serum phenylala-nine (μM) ± 1 SD vs time in days post-vector injection. Reproduced with permission from Harding et al. (42).